Genetic alterations and MRD refine risk assessment for <i>KMT2A</i>-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Emmanuelle Clappier, Emmanuel Raffoux et al.|Blood|2023Cited by 29
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemiaYves Chalandon, Hervé Dombret, Philippe Rousselot et al.|Blood|2024Cited by 28